Want to see SE:INIT full AI Analyst Report?
Initiator Pharma A/S (INIT) Technical Analysis
Technical Sentiment
Overall ConsensusStrong Sell
14Bearish
5Neutral
3Bullish
Technical Analysis ConsensusNeutral
2Bearish
5Neutral
3Bullish
Moving Average ConsensusStrong Sell
12Bearish
0Neutral
0Bullish
1 Day timeframe · Data as of Oct 30, 2026
- Initiator Pharma A/S’s (INIT) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Initiator Pharma A/S is a Buy.
- Initiator Pharma A/S’s (INIT) 20-Day exponential moving average is SEK 2.12, while Initiator Pharma A/S’s (INIT) share price is SEK 1.81, making it a Sell.
- Initiator Pharma A/S’s (INIT) 50-Day exponential moving average is SEK 2.20, while Initiator Pharma A/S’s (INIT) share price is SEK 1.81, making it a Sell.
Initiator Pharma A/S (INIT) Pivot Points
1 Day timeframe · Data as of Oct 30, 2026
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 1.47 | 1.67 | 1.88 | 2.09 | 2.30 | 2.50 | 2.71 |
| Fibonacci | 1.67 | 1.83 | 1.93 | 2.09 | 2.24 | 2.34 | 2.50 |
Initiator Pharma A/S (INIT) Moving Averages
1 Day timeframe · Data as of Oct 30, 2026
| Period | Simple | Exponential |
|---|---|---|
| MA5 | 2.10Sell | 2.08Sell |
| MA10 | 2.20Sell | 2.12Sell |
| MA20 | 2.07Sell | 2.12Sell |
| MA50 | 2.18Sell | 2.20Sell |
| MA100 | 2.38Sell | 2.36Sell |
| MA200 | 2.72Sell | 2.62Sell |
- Initiator Pharma A/S’s (INIT) 10-Day exponential moving average is SEK 2.12, while Initiator Pharma A/S’s (INIT) share price is SEK 1.81, making it a Sell.
- Initiator Pharma A/S’s (INIT) 100-Day exponential moving average is SEK 2.36, while Initiator Pharma A/S’s (INIT) share price is SEK 1.81, making it a Sell.
- Initiator Pharma A/S’s (INIT) stock price is SEK 1.81 and Initiator Pharma A/S’s (INIT) 50-day simple moving average is SEK 2.18, creating a Sell signal.
- Initiator Pharma A/S’s (INIT) stock price is SEK 1.81 and Initiator Pharma A/S’s (INIT) 100-day simple moving average is SEK 2.38, creating a Sell signal.
- Initiator Pharma A/S’s (INIT) stock price is SEK 1.81 and Initiator Pharma A/S’s (INIT) 200-day simple moving average is SEK 2.72, creating a Sell signal.
Initiator Pharma A/S (INIT) Technical Indicators
1 Day timeframe · Data as of Oct 30, 2026
| Name | Value | Implied Action |
|---|---|---|
| RSI (14) | 41.64 | Neutral |
| STOCH (9,6) | 40.22 | Neutral |
| STOCHRSI (14) | 40.22 | Neutral |
| MACD (12,26) | >-0.01 | Buy |
| ADX (14) | 16.35 | Buy |
| Williams %R | -70.97 | Buy |
| CCI (14) | -55.73 | Neutral |
| ATR (14) | 0.22 | - |
| Ultimate Oscillator | 51.60 | Neutral |
| ROC | -3.00 | Sell |
- Initiator Pharma A/S’s (INIT) Relative Strength Index (RSI) is 41.64, creating a Neutral signal.
- Initiator Pharma A/S’s (INIT) Trend Strength Indicator (ADX) is 16.35, creating a Buy signal.
- Initiator Pharma A/S’s (INIT) Commodity Channel Index (CCI) is -55.73, creating a Neutral signal.
- Initiator Pharma A/S’s (INIT) Price Rate of Change (ROC) is -3.00, creating a Sell signal.
unique trading strategy with a flexible screenerTry it Now!
FAQ
Is INIT a Buy, Hold, or Sell?
Based on INIT’s technical indicators on the 1-day timeframe as of Oct 30, 2026, INIT is a Strong Sell.
What is INIT’s RSI (14)?
INIT’s RSI (14) is 41.64, which suggests INIT is a Neutral.
What is INIT’s MACD?
INIT’s MACD is >-0.01, which suggests INIT is a Buy.
What is INIT’s 5-day moving average?
INIT’s 5-day moving average is 2.10, which suggests INIT is a Sell.
What is INIT’s 20-day moving average?
INIT 20-day moving average is 2.07, which suggests INIT is a Sell.
What is INIT’s 50-day moving average?
INIT’s 50-day moving average is 2.18, which suggests INIT is a Sell.
What is INIT’s 200-day moving average?
INIT’s 200-day moving average is 2.72, which suggests INIT is a Sell.
What is INIT’s Williams % R (14)?
INIT’s Williams % R (14) is -70.97, which suggests INIT is a Buy.
What is INIT’s CCI (14)?
INIT’s CCI (14) is -55.73, which suggests INIT is a Neutral.
What is the share price of Initiator Pharma A/S?
Initiator Pharma A/S's share price is N/Akr.
